Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer
Seminars in Cancer Biology · 2025-06 · 111 · 76-88
DOI: 10.1016/j.semcancer.2025.02.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-06. Verfasst von Kate Murray und 28 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, United Kingdom. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer, Biomarkers, Tumor, Artificial Intelligence. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed in its late stages when treatment options are limited. Unlike other common cancers, there are no population-wide screening programmes for PDAC. Thus, early disease detection, although urgently needed, remains elusive. Individuals in certain high-risk groups are, however, offered screening or surveillance. Here we explore advances in understanding high-risk groups for PDAC and efforts to implement biomarker-driven detection of PDAC in these groups. We review current approaches to early detection biomarker development and the use of artificial intelligence as applied to electronic health records (EHRs) and social media. Finally, we address the cost-effectiveness of applying biomarker strategies for early detection of PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, United Kingdom.
- Department of Biology, University of Pisa, Italy.
- Fondazione Pisana per la Scienza ONLUS, Italy.
- Pancreatic Surgery Unit, Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Italy.
- Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Brazil.
- Fondazione Pisana per la Scienza, Scuola Normale Superiore di Pisa, Italy.
Zitieren
APA
Murray, K., Oldfield, L., Stefanova, I., Gentiluomo, M., Aretini, P., O'Sullivan, R., Greenhalf, W., Paiella, S., Aoki, M. N., Pastore, A., Birch-Ford, J., Rao, B. H., Uysal-Onganer, P., Walsh, C. M., Hanna, G. B., Narang, J., Sharma, P., Campa, D., Rizzato, C., …, & Costello, E. (2025). Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. Seminars in Cancer Biology, 111, 76-88. https://doi.org/10.1016/j.semcancer.2025.02.009
Vancouver
Murray K, Oldfield L, Stefanova I, Gentiluomo M, Aretini P, O'Sullivan R, et al. Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. Seminars in Cancer Biology. 2025;111:76-88. doi:10.1016/j.semcancer.2025.02.009
BibTeX
@article{Murray2025,
author = {Murray, Kate and Oldfield, Lucy and Stefanova, Irena and Gentiluomo, Manuel and Aretini, Paolo and O'Sullivan, Rachel and Greenhalf, William and Paiella, Salvatore and Aoki, Mateus N and Pastore, Aldo and Birch-Ford, James and Rao, Bhavana Hemantha and Uysal-Onganer, Pinar and Walsh, Caoimhe M and Hanna, George B and Narang, Jagriti and Sharma, Pradakshina and Campa, Daniele and Rizzato, Cosmeri and Turtoi, Andrei and Sever, Elif Arik and Felici, Alessio and Sucularli, Ceren and Peduzzi, Giulia and Öz, Elif and Sezerman, Osman Uğur and Van der Meer, Robert and Thompson, Nathan and Costello, Eithne},
title = {Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer},
journal = {Seminars in Cancer Biology},
year = {2025},
volume = {111},
pages = {76--88},
doi = {10.1016/j.semcancer.2025.02.009}
}
EUVIMED